GCC Healthcare Quality Scorecard
Healthcare quality is both a development outcome and a development input — healthier populations are more productive, and the quality of healthcare services is a key determinant of livability for both citizens and the expatriate workforce. Across the GCC, all six states have invested heavily in healthcare infrastructure, with ambitions ranging from world-class clinical care to medical tourism hub status. This scorecard benchmarks Qatar and its GCC peers across the principal healthcare quality dimensions.
Health Outcomes
| Outcome Metric | Qatar | Saudi Arabia | UAE | Kuwait | Bahrain | Oman |
|---|---|---|---|---|---|---|
| Life expectancy (years) | ~80 | ~76 | ~78 | ~76 | ~77 | ~78 |
| Infant mortality (per 1,000 live births) | ~5 | ~6 | ~5 | ~7 | ~6 | ~9 |
| Maternal mortality (per 100,000) | ~8 | ~16 | ~3 | ~8 | ~14 | ~17 |
| NCD prevalence (diabetes %) | ~16% | ~18% | ~16% | ~15% | ~17% | ~14% |
| Obesity rate (adults) | ~35% | ~35% | ~31% | ~38% | ~29% | ~27% |
| COVID-19 vaccination rate | ~95%+ | ~75% | ~98%+ | ~80% | ~80% | ~70% |
Note: Qatar (first data column, bold) is the focus country throughout this scorecard.
Qatar achieves the highest life expectancy in the GCC at approximately 80 years, reflecting both healthcare system quality and the demographic composition of the population (a young, working-age expatriate majority). Infant mortality is among the lowest in the region, and the COVID-19 vaccination campaign achieved among the highest coverage rates globally.
Non-communicable diseases — particularly diabetes, obesity, and cardiovascular disease — represent the GCC’s most significant public health challenge. Prevalence rates across the region are among the highest globally, driven by rapid lifestyle changes, dietary shifts, reduced physical activity, and genetic predisposition. Qatar’s diabetes prevalence of approximately 16 percent and obesity rate of approximately 35 percent are consistent with regional patterns and represent a major long-term health expenditure driver.
Healthcare Infrastructure
| Infrastructure Metric | Qatar | Saudi Arabia | UAE | Kuwait | Bahrain | Oman |
|---|---|---|---|---|---|---|
| Hospital beds per 1,000 | ~1.2 | ~2.2 | ~1.3 | ~2.0 | ~2.0 | ~1.5 |
| Physicians per 1,000 | ~2.8 | ~2.6 | ~2.5 | ~2.6 | ~1.0 | ~2.0 |
| Nurses per 1,000 | ~7.5 | ~5.5 | ~5.5 | ~5.0 | ~3.5 | ~4.5 |
| ICU beds per 100,000 | ~10 | ~8 | ~8 | ~7 | ~6 | ~6 |
| Primary care centres (per 100,000) | ~3 | ~4 | ~4 | ~3 | ~3 | ~4 |
| Medical schools | Weill Cornell-Qatar, QU College of Medicine | 30+ (KSU, KAU, Alfaisal, etc.) | 5+ (Khalifa, MBRU, etc.) | 1 (Kuwait University) | 1 (RCSI Bahrain) | 1 (SQU) |
Qatar’s hospital beds per capita ratio of approximately 1.2 is below the GCC average and significantly below Saudi Arabia’s 2.2 and Kuwait’s 2.0. This metric is the most visible infrastructure gap in Qatar’s healthcare system. The relatively high physician density of 2.8 per 1,000 — the highest in the GCC — reflects successful international recruitment, though the workforce remains overwhelmingly expatriate.
Saudi Arabia has the most extensive healthcare infrastructure network in the GCC by absolute scale, driven by its population of over 30 million. The kingdom operates a tiered system of primary care centres, general hospitals, and specialist referral centres, including the flagship King Faisal Specialist Hospital and Research Centre.
Flagship Healthcare Institutions
| Institution | Qatar | Saudi Arabia | UAE | Kuwait | Bahrain | Oman |
|---|---|---|---|---|---|---|
| Primary flagship | Hamad Medical Corporation | King Faisal Specialist Hospital | Cleveland Clinic Abu Dhabi | Mubarak Al-Kabeer Hospital | King Hamad University Hospital | Royal Hospital |
| Specialist flagship | Sidra Medicine (women’s/children’s) | KFSH&RC (oncology, transplant) | Sheikh Shakhbout Medical City | Kuwait Cancer Centre | BDF Hospital | Sultan Qaboos University Hospital |
| Research hospital | Sidra Medicine | KFSH&RC, KAUST Health | Khalifa University research | Limited | Limited | SQU Medical College |
| International accreditation (JCI) | Multiple facilities | Extensive (50+ JCI accredited) | Extensive (50+ JCI accredited) | Several | Several | Several |
Qatar’s healthcare institutional landscape is anchored by two pillars. Hamad Medical Corporation (HMC) operates the public healthcare network, providing acute care, specialised services, ambulatory care, and the 999 ambulance service. HMC has achieved JCI accreditation across its facilities and operates specialised centres for cardiac care, cancer treatment, neuroscience, and rehabilitation.
Sidra Medicine, the Qatar Foundation’s flagship women’s and children’s hospital, represents a $7.4 billion investment in clinical care and biomedical research. Sidra was designed to be both a world-class clinical facility and a research institution, with the ambition of advancing paediatric and maternal medicine in the region. The facility’s operational ramp-up has been gradual, with specialist recruitment and full departmental activation proceeding over several years since the initial opening.
Medical Tourism
| Medical Tourism Metric | Qatar | Saudi Arabia | UAE | Kuwait | Bahrain | Oman |
|---|---|---|---|---|---|---|
| Medical tourism strategy | Emerging (Sidra, HMC specialisms) | Growing (Vision 2030 target) | Established (Dubai Health City, CCA) | Net exporter of patients | Limited | Limited |
| Inbound medical tourists (est.) | Limited | Growing | ~500,000+ (Dubai/Abu Dhabi) | Limited (Kuwaitis travel abroad) | Limited | Limited |
| Specialty positioning | Paediatrics, cardiac, sports medicine | Transplant, oncology | Multi-specialty (CCA, Moorfields, etc.) | N/A | N/A | N/A |
| Medical tourism revenue | Minimal (developing) | Growing | ~$1-2 billion (UAE-wide) | Negative (outbound dominant) | Minimal | Minimal |
The UAE — specifically Dubai and Abu Dhabi — dominates GCC medical tourism through established international hospital brands (Cleveland Clinic Abu Dhabi, Moorfields Eye Hospital Dubai, Mayo Clinic partnership), the Dubai Healthcare City free zone, and proactive medical tourism promotion. The UAE attracts an estimated 500,000 or more medical tourists annually.
Qatar has the institutional quality to compete in selective medical tourism niches — Sidra Medicine’s paediatric specialisation, HMC’s cardiac and sports medicine capabilities, and the country’s strong international connectivity via Qatar Airways. However, a structured medical tourism strategy with dedicated visa pathways, insurance frameworks, and marketing is still in development.
Healthcare Spending
| Spending Metric | Qatar | Saudi Arabia | UAE | Kuwait | Bahrain | Oman |
|---|---|---|---|---|---|---|
| Health spending (% GDP) | ~3.0% | ~5.5% | ~3.5% | ~4.5% | ~4.0% | ~3.8% |
| Health spending per capita ($) | ~$2,520 | ~$1,760 | ~$1,855 | ~$1,710 | ~$1,080 | ~$836 |
| Public share of health spending | ~80% | ~75% | ~70% | ~80%** | ~65% | ~75% |
| Private insurance penetration | Mandatory for employers | Expanding (CCHI mandate) | Mandatory (Abu Dhabi, Dubai) | Government-funded (citizens) | Mixed | Government-dominant |
| Out-of-pocket spending share | ~10% | ~15% | ~20% | ~10% | ~25% | ~15% |
Qatar’s healthcare spending per capita of approximately $2,520 is the highest in the GCC, reflecting both the country’s wealth and the high per-capita cost of operating a healthcare system for a relatively small but dispersed population. Health spending as a percentage of GDP, however, is among the lowest in the GCC at approximately 3.0 percent, reflecting Qatar’s exceptionally high GDP rather than low absolute spending.
The sustainability of healthcare financing across the GCC is an emerging policy challenge. Rising NCD prevalence, aging citizen populations (a gradual trend as life expectancy increases), and expensive technology-driven care are increasing cost pressures. Qatar’s healthcare spending will need to increase in both absolute and relative terms to close the infrastructure gap (particularly hospital beds) and meet rising demand from NCD management.
Healthcare Scorecard (1-5 Scale)
| Dimension | Qatar | Saudi Arabia | UAE | Kuwait | Bahrain | Oman |
|---|---|---|---|---|---|---|
| Health outcomes | 5 | 3 | 4 | 3 | 3 | 4 |
| Infrastructure capacity | 3 | 4 | 3 | 3 | 3 | 3 |
| Clinical quality | 4 | 4 | 5 | 3 | 3 | 3 |
| Medical tourism | 2 | 3 | 5 | 1 | 1 | 1 |
| Spending adequacy | 4 | 4 | 4 | 3 | 3 | 3 |
| Research and innovation | 3 | 4 | 4 | 1 | 2 | 2 |
| Composite Score | 3.5 | 3.7 | 4.2 | 2.3 | 2.5 | 2.7 |
Outlook
Healthcare quality across the GCC is on a convergent trajectory, with all states investing in infrastructure, workforce development, and clinical quality improvement. Qatar’s strong health outcomes — the highest life expectancy and lowest infant mortality in the region — demonstrate that the system delivers results for patients. The infrastructure gap, particularly in hospital beds per capita, is the most pressing challenge and will require sustained investment in physical capacity and workforce expansion.
The NCD burden — diabetes, obesity, cardiovascular disease — is the most significant long-term threat to healthcare system sustainability across the GCC. States that invest most effectively in prevention, primary care capacity, and chronic disease management will achieve better health outcomes at lower cost than those that rely primarily on expensive tertiary care. Qatar’s Primary Health Care Corporation network provides a platform for this preventive approach, but the scale of the NCD challenge requires continued expansion of primary care capabilities and public health interventions.